Brazil study suggests AstraZeneca vaccine is effective against Brazil COVID-19 variant

RIO DE JANEIRO, BRAZIL – Preliminary studies suggest the AstraZeneca vaccine will protect against the P1 variant of the coronavirus, Mauricio Zuma, the head of production at Brazil’s Fiocruz biomedical institute said on Monday, confirming a Reuters report on Friday, March 8th.

The Brazil variant is worrying experts because it is highly contagious and has led several countries to ban travel from the Latin American nation.

Related coverage: FOCUS Survey: Brazil's 2021 inflation now forecast at 4.0%, 2022 outlook also rises · Brazil's Petrobras receives six board nominations from federal government · Shortage of Covid-19 vaccines in Latin America exposes inequality between rich and poor nations · São Paulo governor announces 11 new field hospitals and 140 additional ICU beds

More: Brazil news in English, every day from The Rio Times.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

Brazil runoff, Sunday, October 25: When is the Brazil runoff election. Latest: Brazil runoff polls, Flávio 51%, Lula 49%.